Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

The Nordic-Baltic Bifurcation Study IV (BIF IV)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Johnson & Johnson
Information provided by (Responsible Party):
Niels Ramsing Holm, Aarhus University Hospital Skejby
ClinicalTrials.gov Identifier:
NCT01496638
First received: December 19, 2011
Last updated: September 22, 2016
Last verified: September 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2020
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)